Pharmacogenetics and (Child) Psychiatry

Belinda Wang, MD, PhD
Child and Adolescent Psychiatry Fellow
Dept. of Psychiatry and Behavioral Sciences
UCSF Weill Institute for Neurosciences

Learning objectives:
Upon completion of this activity, participants will be able to:

• Define pharmacogenetics and the concept of pharmacodynamic and pharmacokinetic genes
• List two ways that pharmacogentics could be clinically useful
• List at least two limitations to current pharmacogenetic testing

----------

Child and Adolescent Psychiatry Grand Rounds presentations are for educational purposes and intended only for behavioral/mental health professionals and clinical providers.

Continuing education (CE) credit is available for physicians, psychologists, nurses, and therapists who participate in this activity.